铋杂苯
TL;DR: 铋杂苯 (CAS 289-52-1) is a chemical compound with molecular formula C1=CC=[Bi]C=C1 and molecular weight 274.02 g/mol, supplied by Kehong Biological (Henan Kehong Biological Technology Co., Ltd.) with CRO/CDMO custom synthesis services.
铋杂苯
bismine
Also Known As: Bismin, bismine, Bismabenzene, Bismabenzol, 1-BISMACYCLOHEXA-1,3,5-TRIENE
| Molecular Formula | C1=CC=[Bi]C=C1 |
|---|---|
| Molecular Weight | 274.02 g/mol |
| LogP | 0.5763 |
| Topological Polar Surface Area | 0.0 Ų |
| Hydrogen Bond Donors | 0 |
| Hydrogen Bond Acceptors | 0 |
| Rotatable Bonds | 0 |
| Exact Mass | 274.01953 |
| Heavy Atoms | 6 |
| Complexity | 95.0 |
Chemical Identifiers
| CAS Number | 289-52-1 |
|---|---|
| SMILES | C1=CC=[Bi]C=C1 |
| InChIKey | GJRMOTCKEJLSNY-UHFFFAOYSA-N |
Product Overview
铋杂苯 (CAS 289-52-1), with molecular formula C1=CC=[Bi]C=C1 and molecular weight 274.02 g/mol. IUPAC: bismine.
Chemical Property Profile of 铋杂苯
Property Insights of 铋杂苯
The XLogP value of 0.5763 suggests moderate lipophilicity, balancing water solubility and membrane permeability for 铋杂苯. With a topological polar surface area (TPSA) of 0.0 Ų, 铋杂苯 exhibits relatively low polarity, potentially indicating favorable cell membrane permeability. Following Lipinski's Rule of Five, 铋杂苯 has 0 hydrogen bond donor(s) and 0 hydrogen bond acceptor(s), all within the drug-like range, suggesting favorable oral bioavailability potential.
Frequently Asked Questions
Frequently Asked Questions
What is the CAS number of 铋杂苯?
The CAS number of 铋杂苯 is 289-52-1.
What is the molecular formula of 铋杂苯?
The molecular formula of 铋杂苯 is C1=CC=[Bi]C=C1.
What is the molecular weight of 铋杂苯?
The molecular weight of 铋杂苯 is 274.02 g/mol.
Where can I buy 铋杂苯?
You can request a quote for 铋杂苯 directly from KEHONG BIO. Contact us or email info@kehongbio.com for pricing and availability.
Does KEHONG BIO offer custom synthesis for 铋杂苯?
Yes, KEHONG BIO provides custom synthesis services for 铋杂苯 and related compounds. Contact us with your specific requirements including quantity, purity, and timeline.